Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-30 4:11 pm Sale | 2022-12-27 | 13D | Adverum Biotechnologies, Inc. ADVM | Sonic Fund II L.P. | 463,143 4.600% | -200,000 (-30.16%) | Filing History |
| 2022-02-14 09:08 am Sale | 2021-12-31 | 13G | Fennec Pharmaceuticals Inc. FENC | Sonic Fund II L.P. | 2,469,880 9.500% | -25,873 (-1.04%) | Filing History |
| 2021-04-16 3:11 pm Unchanged | 2021-04-15 | 13D | Adverum Biotechnologies, Inc. ADVM | Sonic Fund II L.P. | 663,143 6.800% | 0 (Unchanged) | Filing History |
| 2021-04-09 4:54 pm Purchase | 2021-03-24 | 13D | Adverum Biotechnologies, Inc. ADVM | Sonic Fund II L.P. | 663,143 6.800% | 50,000 (+8.15%) | Filing History |
| 2021-03-18 2:21 pm Purchase | 2021-03-15 | 13D | Adverum Biotechnologies, Inc. ADVM | Sonic Fund II L.P. | 613,143 6.300% | 91,528 (+17.55%) | Filing History |
| 2021-02-16 3:46 pm Purchase | 2020-12-17 | 13G | Adverum Biotechnologies, Inc. ADVM | Sonic Fund II L.P. | 521,615 5.400% | 96,887 (+22.81%) | Filing History |
| 2021-02-16 3:44 pm Purchase | 2020-04-30 | 13G | Fennec Pharmaceuticals Inc. FENC | Sonic Fund II L.P. | 2,495,753 9.700% | 2,495,753 (New Position) | Filing History |
| 2020-08-20 2:21 pm Purchase | 2020-08-18 | 13D | Adverum Biotechnologies, Inc. ADVM | Sonic Fund II L.P. | 424,728 4.400% | 45,172 (+11.90%) | Filing History |